Mini ReviewOpen Access

Diabetes Mellitus Therapy

Volume 3 - Issue 5

Ahmed M Abu-Dief*

Author Information Open or Close
- Chemistry Department, Faculty of Science, Sohag University, Egypt
*Corresponding author: Ahmed M Abu-Dief, Chemistry Department, Faculty of Science, Sohag University-82524, Egypt

Received: April 12, 2018; Published: April 19, 2018

DOI: 10.26717/BJSTR.2018.03.000978

Full Text PDF

To view the Full Article Peer-reviewed Article PDF

Abstract

Diabetes is depicted by hyperglycemia, altered lipids, carbohydrates, and proteins metabolism which affect the patient nature of life in terms of social, psychological well- being as well as physical ill health [1,2]. Two forms of diabetes (Types 1 and 2) differ in their pathogenesis, but both have hyperglycemia as a common hall mark. In type 2 diabetes, hyperglycemia caused due to deterioration in insulin secretion combined with or without impairment of insulin action [3]. The World Health Organization declared that worldwide global population is in the midst of a diabetes epidemic. The people in Southeast Asia and Western Pacific are being under greater risk, and the majority of patients have type 2 diabetes. Insulin impedance typically precedes the onset of type 2 diabetes and is commonly accompanied by other cardiovascular risk factors such as dyslipidemia, hypertension, and prothrombotic factors [4]. Diabetes mellitus (DM), a leading non removable disease with multiple etiologies, is deemed as one of the five leading causes of death in the world. The total number of people with diabetes is projected to rise from 171 million in 2000 to 366 million in 2030 [5].

Introduction| References